IP News

IP News

Federal Circuit Affirms ‘pH 13 or Higher’ Means ‘pH 12.98 or Higher’ in Actelion v. Mylan: Generic Epoprostenol Cleared of Infringement

The Federal Circuit on May 13, 2026 affirmed Mylan's generic epoprostenol does not infringe Actelion's Veletri patents, holding 'pH of 13 or higher' means 'pH 12.98 or higher' and foreclosing the doctrine of equivalents under both prosecution history estoppel and the disclosure-dedication rule.
IP News

Chrome Hearts Voluntarily Dismisses Trademark Lawsuit Against Neil Young’s Band “The Chrome Hearts”

On May 14, 2026, luxury brand Chrome Hearts voluntarily dismissed its trademark suit against Neil Young's backing band 'The Chrome Hearts.' The case, filed the previous year, centered on apparel-class conflicts with artist merchandise. Young plans to keep the band's name and continue touring and releases under it.
IP News

EPO Reveals 12 Finalists for European Inventor Award 2026: Malaria Vaccine, Quantum Sensing, and Semiconductor Probe Cards Among Honorees

On May 13, 2026, the EPO unveiled 12 finalists for the European Inventor Award 2026. Honorees include Sir Adrian Hill (R21/Matrix-M malaria vaccine), Mikko Möttönen (cryogenic quantum sensing), and Technoprobe (semiconductor probe cards) across Industry, Research, SMEs and Non-EPO Countries. Ceremony in Berlin on July 2.
IP News

Federal Circuit Affirms Dismissal of Nesarikar v. USPTO Pro Se Suit Over Micro-Entity Denial and Article III Standing

The U.S. Court of Appeals for the Federal Circuit (CAFC) affirmed on May 12, 2026 the dismissal of a pro se lawsuit brou...
IP News

USPTO Modernizes Design Patent Examination for GUIs, Icons, and VR/AR – Dropping the Strijland-Era Screen Requirement

The U.S. Patent and Trademark Office (USPTO) published its Supplemental Guidance for Examination of Design Patent Applic...
IP News

Federal Circuit Rules Section 285 Fee Awards Do Not Reach Parallel IPR Proceedings in Extremity Medical v. Nextremity

The U.S. Court of Appeals for the Federal Circuit (CAFC) ruled on May 12, 2026 in Extremity Medical, LLC v. Nextremity S...
IP News

PTAB Decision Upholds Broad Institute’s CRISPR Priority in Landmark Patent Ruling

The Patent Trial and Appeal Board (PTAB) has affirmed the Broad Institute's priority claims for CRISPR-Cas9 patents cove…
IP News

Federal Circuit Holds ‘About’ Indefinite in pH Range Claim — Enviro Tech v. Safe Foods Precedential Opinion

The U.S. Court of Appeals for the Federal Circuit (CAFC) on 4 May 2026 issued a precedential decision in Enviro Tech Che...
IP News

EPO Enlarged Board Concludes Oral Proceedings in G 1/25, Signals Continued Mandatory Description Adaptation

The Enlarged Board of Appeal of the European Patent Office (EPO) closed oral proceedings in referral G 1/25 on 8 May 202...
IP News

UK IPO Publishes Corporate Plan 2026-2027: One IPO Transformation, AI and Copyright, and SEP Reforms Take Centre Stage

The UK Intellectual Property Office (IPO) published its Corporate Plan 2026 to 2027 on May 11, 2026, setting out the age...